Apple’s Jobs Had Liver Transplant – Analyst Blog
Source: http://www.zacks.com/stock/news/21309/Apple%27s+Jobs+Had+Liver+Transplant+-+Analyst+BlogPosted on Monday, June 22nd, 2009 | In Market Commentary, Stocks to Watch
It has been reported the Steve Jobs, CEO of Apple Inc. (AAPL), had a liver transplant about two months ago, possibly due to cancer that may have spread from the pancreas.
There are two major effects that have to be watched. First is the possibility of tissue rejection. Over a two month period any rejection should have been apparent. Second is the possibility of cancer cells still existing in the body, and these may spread to the new liver.
Mr. Jobs may require continued treatment such as blood thinners and chemotherapy. Such treatments are not easy on the body and may prevent a full return to work.
However, as we have mentioned, Apple Inc. is more than one person. There are certainly a number of creative people that can carry on the traditions established by Mr. Jobs.
Read the full analyst report on “AAPL”
Zacks Investment Research
Last 5 posts by Zacks Market Commentaries
- CNP & FPL Ink Pipeline Deal - Analyst Blog - November 20th, 2009
- Buffett Borrows for Rail Acquisition - Analyst Blog - November 20th, 2009
- Stone Energy Outdoes Estimates - Analyst Blog - November 20th, 2009
- Smucker's Beats, Raises Guidance - Analyst Blog - November 20th, 2009
- GameStop Meets Expectations - Analyst Blog - November 20th, 2009
 About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.